Search Results - "Vlachonicolis, J."

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer by Mavroudis, D., Papadakis, E., Veslemes, M., Tsiafaki, X., Stavrakakis, J., Kouroussis, C., Kakolyris, S., Bania, E., Jordanoglou, J., Agelidou, M., Vlachonicolis, J.

“…Background Previous phase I-II studies have shown that the combination of paclitaxel-cisplatin-etoposide (TEP) is very active and well tolerated in patients…”
Get full text

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial by Mavroudis, D., Malamos, N., Alexopoulos, A., Kourousis, Ch, Agelaki, S., Sarra, E., Potamianou, A., Kosmas, Ch, Rigatos, G., Giannakakis, Th, Kalbakis, K., Apostolaki, F., Vlachonicolis, J., Kakolyris, S., Samonis, G., Georgoulias, V.

“…Purpose: The activity of the docetaxel-gemcitabine combination in women with disease progression after initial chemotherapy for metastatic breast cancer (MBC)…”
Get full text

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study by Georgoulias, V., Androulakis, N., Dimopoulos, A. M., Kourousis, C., Kakolyris, S., Papadakis, E., Apostolopoulou, F., Papadimitriou, C., Vossos, A., Agelidou, M., Heras, P., Tzannes, S., Vlachonicolis, J., Mavromanolakis, E., Hatzidaki, D.

“…Purpose: To evaluate the efficacy and safety of the docetaxelcisplatin combination in patients with advanced non-small-cell lung cancer (NSCLC). Patients and…”
Get full text

Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study by Alexopoulos, A., Kouroussis, C., Malamos, N., Kakolyris, S., Kalbakis, K., Kosmas, C., Mavroudis, D., Agelaki, S., Vlachonicolis, J., Sarra, E., Rigatos, G., Georgoulias, V.

“…Summary Purpose: To evaluate the activity and tolerance of docetaxel in combination with mitoxantrone and granulocyte colonystimulating factor (G-CSF) as…”
Get full text

First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer by KAKOLYRIS, S, SAMONIS, G, KOUKOURAKIS, M, VLACHONICOLIS, J, KALBAKIS, K, AGELAKI, S, CHALKIADAKIS, G, SANIDAS, E, TSIFTSIS, D, GEORGOULIAS, V

“…Fifty patients with stage IIIB and IV breast cancer entered a prospective study receiving combination chemotherapy consisting of mitoxantrone (8 mg/m2) on day…”
Get full text

Psychiatric case identification in two Athenian communities: estimation of the probable prevalence by Madianos, M G, Tomaras, V, Kapsali, A, Vaidakis, N, Vlachonicolis, J, Stefanis, C N

“…A two stage cross sectional survey on the prevalence of psychiatric disorders was conducted in a sample of 1,574 adults, residents of two boroughs in the…”
Get more information

Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial by GEORGOULIAS, V, KOUROUSSIS, C, HATZAKIS, K, KALBAKIS, K, KOTSAKIS, A, VARDAKIS, N, VLACHONICOLIS, J, ANDROULAKIS, N, KAKOLYRIS, S, DIMOPOULOS, M.-A, PAPADAKIS, E, BOUROS, D, APOSTOLOPOULOU, F, PAPODIMITRIOU, C, AGELIDOU, A

“…To evaluate the tolerance and efficacy of the combination of docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer (NSCLC). Fifty-one…”
Get full text

Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation by Sara, E, Kotsakis, A, Souklakos, J, Kourousis, C, Kakolyris, S, Mavromanolakis, E, Vlachonicolis, J, Georgoulias, V

“…A phenolypic analysis of peripheral blood lymphocytes was carried out in order to investigate the lymphopenia developed in some patients with solid tumors…”
Get more information

Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer by KOUROUSIS, C, KAKOLYRIS, S, ANDROULAKIS, N, HERAS, P, VLACHONICOLIS, J, VAMVAKAS, L, VLATA, M, HATZIDAKI, D, SAMONIS, G, GEORGOULIAS, V

“…The tolerance and the efficacy of the paclitaxel-vinorelbine-cisplatin combination (PVC regimen) was evaluated in 33 patients with anthracycline-resistant…”
Get full text

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study by Androulakis, N., Kourousis, C., Kakolyris, S., Dimopoulos, A.M., Papadakis, E., Apostolopoulou, F., Vlachonicolis, J., Hatzidaki, D., Samonis, G., Georgoulias, V.

Get full text

Lymphocyte abnormalities during post-chemotherapy myelosuppression and bone marrow regeneration in patients with solid tumors by Georgoulias, V., Papadaki, S., Sara, E., Kourousis, C., Kotsakis, T., Vamvakas, L., Stefanakis, E., Mavromanolakis, E.C., Vlachonicolis, J.

Get full text

Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group by Mavroudis, D, Malamos, N, Alexopoulos, A, Kourousis, C, Agelaki, S, Sarra, E, Potamianou, A, Kosmas, C, Rigatos, G, Giannakakis, T, Kalbakis, K, Apostolaki, F, Vlachonicolis, J, Kakolyris, S, Samonis, G, Georgoulias, V

“…The activity of the docetaxel-gemcitabine combination in women with disease progression after initial chemotherapy for metastatic breast cancer (MBC) was…”
Get full text

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial by Georgoulias, V, Kourousis, Ch, Androulakis, N, Kakolyris, S, Dimopoulos, MA, Papadakis, E, Bouros, D, Apostolopoulou, F, Papadimitriou, Ch, Agelidou, A, Tzianni, V, Apostolaki, F, Hatzakis, K, Kalbakis, K, Kotsakis, A, Sarra, E, Vardakis, N, Vlachonicolis, J

Get full text